\-\ Texto\\:\\ \ \(0\)\
\-\ \\+3\\ hyperreflexia\\ of\\ the\\ lower\\ extremities\ \(1\)\
\-\ patient\\ is\\ currently\\ being\\ treated\\ conservatively\\ with\\ pain\\ meds\\ as\\ needed\\.\ \(0\)\
\-\ mri\\ of\\ the\\ spine\\ demonstrates\\ proliferation\\ of\\ the\\ dorsal\\ epidural\\ fat\\ associated\\ with\\ complete\\ effacement\\ of\\ the\\ dorsal\\ sub\\ arachnoid\\ space\\ from\\ the\\ t3\\ \\-\\ t9\\ levels\\ which\\ results\\ in\\ moderate\\ central\\ canal\\ stenosis\\ mild\\ ventral\\ cord\\ flattening\\ at\\ the\\ t6\\-7\\ level\\.\\ \\ there\\ is\\ also\\ multilevel\\ disk\\ disease\\.\ \(0\)\
\-\ epidural\\ lipomatosis\ \(4\)\
\-\ \\â\\€\\¢\\ epidural\\ lipomatosis\ \(1\)\
\-\ \\â\\€\\¢\\ epidural\\ spread\\ of\\ liposarcoma\ \(1\)\
\-\ \\â\\€\\¢\\ extradural\\ lipoma\ \(1\)\
\-\ 76\\ y\\.o\\.\\ man\\ presents\\ with\\ back\\ pain\\ and\\ hyperreflexia\\ in\\ the\\ lower\\ extremities\\.\\ \\ mri\\ of\\ brain\\ showed\\ no\\ focal\\ abnormalities\\.\ \(0\)\
\-\ the\\ cause\\ for\\ this\\ specific\\ case\\ of\\ epidural\\ lipomatosis\\ is\\ currently\\ unknown\\.\\ \\ this\\ man\\ is\\ not\\ obease\\ nor\\ does\\ he\\ currently\\ have\\ a\\ diagnosed\\ endocrinopathy\\.\\ \\ additionally\\,\\ he\\ does\\ not\\ take\\ steriods\\ for\\ some\\ underlying\\ condition\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ epidural\\:\\ 0\\.42235250317202283\ \(0\)\
\-\ lipomatosis\\:\\ 0\\.3783964467206544\ \(0\)\
\-\ hyperreflexia\\:\\ 0\\.23643276709346\ \(0\)\
\-\ currently\\:\\ 0\\.2143309287705503\ \(0\)\
\-\ dorsal\\:\\ 0\\.17157744173377681\ \(0\)\
\-\ obease\\:\\ 0\\.1487344233214842\ \(0\)\
\-\ the\\:\\ 0\\.14846212261665143\ \(0\)\
\-\ endocrinopathy\\:\\ 0\\.14212368183970928\ \(0\)\
\-\ extremities\\:\\ 0\\.14135741004940877\ \(0\)\
\-\ steriods\\:\\ 0\\.13082254463240958\ \(0\)\
\-\ does\\:\\ 0\\.12859199311051858\ \(0\)\
\-\ of\\:\\ 0\\.1274039664006481\ \(0\)\
\-\ t9\\:\\ 0\\.11384258213007475\ \(0\)\
\-\ multilevel\\:\\ 0\\.11384258213007475\ \(0\)\
\-\ he\\:\\ 0\\.11014769717111915\ \(0\)\
\-\ extradural\\:\\ 0\\.1069152463394303\ \(0\)\
\-\ is\\:\\ 0\\.10187964356114215\ \(0\)\
\-\ meds\\:\\ 0\\.10160952873603524\ \(0\)\
\-\ t3\\:\\ 0\\.1007280116453948\ \(0\)\
\-\ proliferation\\:\\ 0\\.09989172092107873\ \(0\)\
\-\ ventral\\:\\ 0\\.09989172092107873\ \(0\)\
\-\ liposarcoma\\:\\ 0\\.0994891302293514\ \(0\)\
\-\ man\\:\\ 0\\.09847546132009577\ \(0\)\
\-\ mri\\:\\ 0\\.09548050360171224\ \(0\)\
\-\ lower\\:\\ 0\\.09505078987193032\ \(0\)\
\-\ sub\\:\\ 0\\.09440584574312366\ \(0\)\
\-\ take\\:\\ 0\\.09440584574312366\ \(0\)\
\-\ conservatively\\:\\ 0\\.09355500428637784\ \(0\)\
\-\ effacement\\:\\ 0\\.09222873728498569\ \(0\)\
\-\ flattening\\:\\ 0\\.09172703325091858\ \(0\)\
\-\ disk\\:\\ 0\\.09148185427570305\ \(0\)\
\-\ 76\\:\\ 0\\.09148185427570305\ \(0\)\
\-\ nor\\:\\ 0\\.09053642454106539\ \(0\)\
\-\ arachnoid\\:\\ 0\\.08495243014257234\ \(0\)\
\-\ spread\\:\\ 0\\.08354738083018477\ \(0\)\
\-\ lipoma\\:\\ 0\\.08067481835362422\ \(0\)\
\-\ needed\\:\\ 0\\.0767877424724122\ \(0\)\
\-\ additionally\\:\\ 0\\.07659130522140688\ \(0\)\
\-\ underlying\\:\\ 0\\.07592183485601853\ \(0\)\
\-\ condition\\:\\ 0\\.07431685859591106\ \(0\)\
\-\ levels\\:\\ 0\\.07373301789137711\ \(0\)\
\-\ not\\:\\ 0\\.0734319189728102\ \(0\)\
\-\ results\\:\\ 0\\.07247217002695495\ \(0\)\
\-\ canal\\:\\ 0\\.07158666221432536\ \(0\)\
\-\ stenosis\\:\\ 0\\.07074678067519344\ \(0\)\
\-\ specific\\:\\ 0\\.07047616708341073\ \(0\)\
\-\ unknown\\:\\ 0\\.07047616708341073\ \(0\)\
\-\ moderate\\:\\ 0\\.0698186548161716\ \(0\)\
\-\ cord\\:\\ 0\\.06894052981846036\ \(0\)\
\-\ abnormalities\\:\\ 0\\.06736993830488727\ \(0\)\
\-\ diagnosed\\:\\ 0\\.06736993830488727\ \(0\)\
\-\ pain\\:\\ 0\\.06656085693080367\ \(0\)\
\-\ complete\\:\\ 0\\.06519282984674932\ \(0\)\
\-\ being\\:\\ 0\\.06480918639086193\ \(0\)\
\-\ this\\:\\ 0\\.0639160338465618\ \(0\)\
\-\ cause\\:\\ 0\\.06335897816393853\ \(0\)\
\-\ central\\:\\ 0\\.06210741038133202\ \(0\)\
\-\ back\\:\\ 0\\.062027291819101\ \(0\)\
\-\ showed\\:\\ 0\\.06194756503624559\ \(0\)\
\-\ space\\:\\ 0\\.06190784736835706\ \(0\)\
\-\ spine\\:\\ 0\\.061438632407688355\ \(0\)\
\-\ some\\:\\ 0\\.05851751760887188\ \(0\)\
\-\ brain\\:\\ 0\\.05797875214860495\ \(0\)\
\-\ treated\\:\\ 0\\.057916522704335956\ \(0\)\
\-\ fat\\:\\ 0\\.057854529874494715\ \(0\)\
\-\ for\\:\\ 0\\.05637789301830249\ \(0\)\
\-\ level\\:\\ 0\\.056180092277868375\ \(0\)\
\-\ focal\\:\\ 0\\.055631080993103356\ \(0\)\
\-\ with\\:\\ 0\\.05463432438866306\ \(0\)\
\-\ mild\\:\\ 0\\.05272159996930539\ \(0\)\
\-\ associated\\:\\ 0\\.04902033951132841\ \(0\)\
\-\ demonstrates\\:\\ 0\\.04672444339266109\ \(0\)\
\-\ case\\:\\ 0\\.04672444339266109\ \(0\)\
\-\ have\\:\\ 0\\.04646084315886122\ \(0\)\
\-\ in\\:\\ 0\\.046272996432820256\ \(0\)\
\-\ presents\\:\\ 0\\.044739959389814773\ \(0\)\
\-\ also\\:\\ 0\\.043746645673898514\ \(0\)\
\-\ which\\:\\ 0\\.04229006600877993\ \(0\)\
\-\ disease\\:\\ 0\\.03903998001926651\ \(0\)\
\-\ as\\:\\ 0\\.03736320356238048\ \(0\)\
\-\ there\\:\\ 0\\.03700619710703537\ \(0\)\
\-\ from\\:\\ 0\\.03693743962145185\ \(0\)\
\-\ at\\:\\ 0\\.03512897249362914\ \(0\)\
\-\ patient\\:\\ 0\\.030249690989722997\ \(0\)\
\-\ no\\:\\ 0\\.030244001199190514\ \(0\)\
\-\ and\\:\\ 0\\.019218238779082103\ \(0\)\
